Summary
The process of designing and implementing clinical trials hasn’t changed much over the decades — which may be why 1 in 5 clinical trials fail due to insufficient patient enrollment, and fewer than 5 percent of adult patients take part in clinical trials at all.
Click below to read more at The Future of Personal Health.
View Publication
The True Cost of Ineffective Clinical Trials
Read more
You may also be interested in:
Blog
Easing the Rare Patient's Burden in Clinical Trials
Read Story
Case Study
PRA Successfully Rescues Phase II Hematology Study
A phase II single-blind, randomized, placebo-controlled trial to study the efficacy and safety of Study Drug administered as adjunctive treatment to…
View Resource
Newsletter
RARE DISEASES NEWSLETTER Volume 15, December 2019
View Resource
View all related content and resources for Rare Disease
Explore Insights